Cboe UK • EUR Pharma Mar, S.A. (PHME.XC) Follow Compare 68.82 0.00 (0.00%) As of October 16 at 3:10:28 PM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for PHME.XC 1D 5D 0.00% 1M 0.00% 6M 61.79% YTD 110.35% 1Y 110.35% 5Y 99.01% All 42.32% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PHME.XC View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations High Growth Tech Stocks With Promising Potential 3 Stocks Estimated To Be Trading At Up To 49.2% Below Intrinsic Value 3 Insider-Favored Growth Companies To Watch High Growth Tech Stocks To Watch In The Current Market Pharma Mar SA Reports Strong Revenue Growth in 2024 3 Growth Stocks With High Insider Ownership And Earnings Up To 55% High Growth Tech Highlights Three Promising Stocks PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer September 2024's Top Growth Picks With High Insider Ownership 3 Growth Stocks With Insider Ownership Up To 14% 3 Growth Companies With High Insider Ownership And Up To 23% Revenue Growth